Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women : a short version Cochrane systematic review with meta-analysis
dc.contributor.author | Dumoulin, Chantal | |
dc.contributor.author | Hay-Smith, Jean | |
dc.contributor.author | Mac Habée-Séguin, Gabrielle | |
dc.contributor.author | Mercier, Joanie | |
dc.date.accessioned | 2017-01-05T21:08:13Z | |
dc.date.available | MONTHS_WITHHELD:12 | fr |
dc.date.available | 2017-01-05T21:08:13Z | |
dc.date.issued | 2015-04-10 | |
dc.identifier.uri | http://hdl.handle.net/1866/16364 | |
dc.subject | pelvic floor muscle training | fr |
dc.subject | urinary incontinence | fr |
dc.subject | women | fr |
dc.title | Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women : a short version Cochrane systematic review with meta-analysis | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. École de réadaptation | fr |
UdeM.statut | Professeur(e) / Professor | fr |
dc.identifier.doi | 10.1002/nau.22700 | |
dcterms.abstract | Background Pelvic floor muscle training (PFMT) is a commonly used physical therapy for women with urinary incontinence (UI). Objectives To determine the effects of PFMT for women with UI in comparison to no treatment, placebo or other inactive control treatments. Search Methods Cochrane Incontinence Group Specialized Register, (searched 15 April 2013). Selection Criteria Randomized or quasi-randomized trials in women with stress, urgency or mixed UI (based on symptoms, signs, or urodynamics). Data Collection and Analysis At least two independent review authors carried out trial screening, selection, risk of bias assessment and data abstraction. Trials were subgrouped by UI diagnosis. The quality of evidence was assessed by adopting the (GRADE) approach. Results Twenty-one trials (1281 women) were included; 18 trials (1051 women) contributed data to the meta-analysis. In women with stress UI, there was high quality evidence that PFMT is associated with cure (RR 8.38; 95% CI 3.68 to 19.07) and moderate quality evidence of cure or improvement (RR 17.33; 95% CI 4.31 to 69.64). In women with any type of UI, there was also moderate quality evidence that PFMT is associated with cure (RR 5.5; 95% CI 2.87–10.52), or cure and improvement (RR 2.39; 95% CI 1.64–3.47). Conclusions The addition of seven new trials did not change the essential findings of the earlier version of this review. In this iteration, using the GRADE quality criteria strengthened the recommendations for PFMT and a wider range of secondary outcomes (also generally in favor of PFMT) were reported. | fr |
dcterms.isPartOf | urn:ISSN:0733-2467 | |
dcterms.isPartOf | urn:ISSN:1520-6777 | |
dcterms.language | eng | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | |
oaire.citationTitle | Neurology and urodynynamics | |
oaire.citationVolume | 34 | |
oaire.citationIssue | 4 | |
oaire.citationStartPage | 300 | |
oaire.citationEndPage | 308 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.